Skip to content



Unlocking the Benefits of Medicinal Cannabis and CBD

With over 15 years of analytical testing experience, we have expanded our services to include validated methods for cannabis-based products and cannabidiol (CBD) to ensure quality, safety, and efficacy.



scientist holding cannabis plant and cbd oil bottle

Our Commitment to Safer Cannabinoid Delivery

We are committed to using our scientific knowledge and experience to help clients demonstrate the safety and efficacy of their medicinal cannabis and CBD products to regulators to increase legal access to new cannabis-based therapeutic remedies that will improve people's lives. With broad experience in medical and consumer inhalation devices and smart drug delivery systems, we aim to become an innovation partner for the cannabinoid industry.    

scientist holding test tube to test cbd

Addressing Unmet Clinical and Therapeutic Patient Needs

The rapid growth of the cannabinoid industry presents a unique opportunity for companies to innovate new products and provide novel solutions for advancing human health. Building regulatory and consumer acceptance for your product is essential for commercial success in this new and rapidly evolving pharmaceutical and consumer category. Ensuring product quality and efficacy through high-quality analytical testing, product stability studies, and expert toxicology consultancy will enable you to build the required scientific evidence to support regulatory submissions and ongoing compliance.

Experts in Cannabis Quality and Efficacy 

As the holder of a UK Home Office controlled drugs license, we serve a global roster of clients offering a wide range of services for both medicinal cannabis and CBD products.

    • Regulatory consultancy specializing in EU and UK cannabis regulation.
    • EU and UK Novel Food Application scientific consultancy and analytical testing support for full applications, filling gaps in an existing application, or responding to a deficiency letter from regulatory authorities.
    • Product realization services, including design for regulatory approval, gap analysis for chosen regulatory pathways, product optimization, reformulation, etc.
    • Aerosol testing, characterization, and assessment.
    • Stand-alone toxicology consultancy services.
    • Stand-alone stability study services.
    • Method development, validation, and technology transfer.
Broughton scientist working with laboratory equipment

Cannabis Analytical Testing

From high-quality sample handling to state-of-the-art GMP compliant testing facilities and expert scientific insight into test results, your medicinal cannabis or CBD project will be supported by scientific experts with years of analytical testing experience. Our scientists will be on hand every step of the way to ensure you understand the data and can make the best decisions throughout your cannabis or CBD product development or regulatory compliance project. All communication will be proactive, timely, and from a subject matter expert that understands your business needs, helping accelerate your project timelines and build trust.


Read more

cannabis leaf on dark background
Two Broughton cannabinoid consultants working together at a computer

Scientific and Regulatory Consultancy

Finding a team of like-minded experts is always difficult, especially when the stakes are high and success may seem uncertain. Helping you understand the scientific and regulatory processes, we work with your in-house team to troubleshoot problems and decide the best steps forward for your project. 

Let us share our expertise and deep industry knowledge to help accelerate your project and make it a commercial success. Working with a cross-functional and multidisciplinary team across chemistry, toxicology, and clinical areas, we specialize in strategic planning across different stages of the product development lifecycle. Aligning regulatory registration goals to every stage to de-risk your project, we develop high-value scientific studies that speed your medicinal cannabis or CBD product to market.


Read more

Medicinal Cannabis and CBD Regulation

The regulatory environment for medicinal cannabis and CBD is rapidly evolving as the industry develops. Keeping abreast of regulatory changes and interpretations can be difficult. Our experienced team of consultants will guide you through each step of the process and advise on the best regulatory pathway for your project’s strategic objectives. We specialize in building tailor-made scientific strategies for product development, regulatory submissions, and post market compliance projects to help you succeed in whichever regulatory pathway you choose.

  • EU and UK Novel Food Regulations for edible CBD products
  • UK Unlicensed cannabis-based products for medical use in humans (CBPM)
  • UK Licensed CBPMs
  • UK Licensed cannabis-based medicines

Cannabinoid Services Resources 

Learn more about we can help bring your medicinal cannabis and CBD product to market high-quality analytical testing integrated with expertise in scientific strategy and an understanding of global regulatory pathways.


Whitepaper: Does CBD Really Harm the Liver?

Both the FDA and EFSA have raised several concerns about CBD as supplements and as an ingredient in food and drinks, citing potential liver damage as a possible side effect. Is CBD really that toxic to the liver? To find out, toxicologist Cristelle Santos looks at the scientific evidence.

Click to download


Cannabis Services

Enhancing the positive reputation of cannabis by accelerating safe, efficacious, and high-quality cannabis products to a regulated market. Learn more about our cannabis services. 

Click to download


Whitepaper: A Summary of the Legal Status and Regulatory Pathways to Market for Cannabinoid Products in the UK Market

Broughton summarises the regulatory pathways available for cannabinoid products in the UK market and the legal requirements for each potential market route. 

Click to download


Whitepaper: Review of the degradation pathways of cannabinoids, the potential impact on medicinal and consumer products, and discussion of mitigation solutions

In this whitepaper, Broughton discusses the susceptibility of cannabinoids to degrade and summarizes the main degradation pathways of the primary cannabinoid products on the market; tetrahydrocannabinol (THC) and Cannabidiol (CBD). 

Click to download


Whitepaper: The importance of the human endocannabinoid system when developing therapeutic cannabis products

To develop cannabis products that can both enhance the quality of life of cannabis users and comply with current and future regulations, we believe that fi rst we need to understand what cannabis is, how people use it, and how it affects the human body and mind. This white paper aims to provide essential but concise information about these areas, supported by scientific evidence.

Click to download


Medicinal Cannabis and CBD Services

Learn more about our UK and EU Novel Food Application scientific consultancy and analytical testing support.

Click to download

Speak to an Expert

Arrange a meeting with a scientific or regulatory expert to discuss your project and learn how we can help accelerate your product to market to maximize your success.

Contact Us

Cannabis Industry Insight and Expert Opinion

Learn more about our activities and gain insight from our scientific and regulatory experts

Visit the blog